Table 2.
Criteria for MS |
|||
---|---|---|---|
Parameter | <3 (n =389) | ≥(n =73) | P-value* |
Total testosterone, ng/dL, mean ±standard deviation | 433 ±129 | 399 ±139 | .03 |
Bioavailable testosterone, ng/dL, median (IQR) | 86.6 (50.7) | 98.3 (46.1) | .17 |
Free testosterone, ng/dL, median (IQR) | 3.8 (2.2) | 4.2 (1.9) | .22 |
Sex hormone binding globulin, nmoL/L, median (IQR) | 104.0 (62.2) | 83.6 (41.6) | <.001 |
Dehydroepiandrosterone sulphate, μg/dL, median (IQR) | 66.4 (66.5) | 71.1 (78.4) | .98 |
Cortisol, nmol/L, median (IQR) | 356.4 (183.2) | 349.9 (184.6) | .16 |
Insulin-like growth factor-1, ng/mL, median (IQR) | 124.8 (68.3) | 132.0 (69.4) | .13 |
Leptin, ng/mL, median (IQR) | 4.2 (5.1) | 8.6 (6.6) | <.001 |
Differences in parameters between patients with and without MS were tested using age adjusted analysis of covariance.
IQR =interquartile range.